Craniofrontonasal dysplasia

From WikiMD's Medical Encyclopedia

Revision as of 05:02, 22 February 2024 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Craniofrontonasal dysplasia (CFND) is a very rare genetic condition that primarily affects the head and face. The condition is characterized by malformations of the skull, face, and limbs, as well as other abnormalities. CFND is caused by mutations in the EFNB1 gene and is inherited in an X-linked dominant manner.

CT-scan of the skull of a patient with coronal synostosis, orbital hypertelorism, and facial asymmetry as part of craniofrontonasal dysplasia.
Picture of longitudinal ridging and splitting of the toenails as part of craniofrontonasal dysplasia.

Symptoms

The symptoms of CFND can vary greatly from person to person. However, common symptoms include:

Causes

CFND is caused by mutations in the EFNB1 gene. This gene provides instructions for making a protein called ephrin-B1, which is involved in the development of tissues and organs during embryonic development. Mutations in the EFNB1 gene disrupt the normal development of these tissues and organs, leading to the symptoms of CFND.

Diagnosis

The diagnosis of CFND is typically based on a clinical evaluation, detailed patient history, and a variety of specialized tests. These tests can include genetic testing, imaging studies, and physical examination.

Treatment

There is currently no cure for CFND. Treatment is symptomatic and supportive, and may include surgery to correct craniofacial abnormalities, physical therapy, and speech therapy.

Prognosis

The prognosis for individuals with CFND varies. Some individuals may have mild symptoms and live a normal life, while others may have severe symptoms that require extensive medical care.

See also

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.